Results show that percutaneous hepatic perfusion with CHEMOSAT® is an effective and safe treatment option for patients with advanced cholangiocarcinoma and has the potential to prolong life in ...
This prospective study included 135 patients (median age, 67 years; 66 women) who underwent MRI-guided SBRT for liver metastases across seven international centres between April 2019 and April 2023.
QUEENSBURY, N.Y., November 18, 2025--(BUSINESS WIRE)--Delcath Systems, Inc. (Nasdaq: DCTH), ("Delcath" or the "Company") an interventional oncology company focused on the treatment of primary and ...
Adding MRI to CT may improve the accuracy of detecting nonviable disappearing liver metastases than CT alone among patients with initially unresectable colorectal liver metastases. However, confirmed ...
69 weeks (16 months) median hPFS in patients with uveal melanoma. 38 weeks (8.5 months) median hPFS in patients with cholangiocarcinoma. Importance of Repeated Treatments: The investigators’ approach ...
Resection of liver metastases is considered the only treatment with curative potential for patients with metastatic colorectal cancer to the liver (CRLM). However, only a minority of patients with ...
Persistently elevated liver enzymes may be caused by certain types of cancer, including liver, colon, breast, stomach, pancreas, and skin cancers. Liver enzymes are proteins produced by your liver.
Please provide your email address to receive an email when new articles are posted on . The regional treatment conferred a significantly higher overall response rate than best alternative care. Median ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. In a preclinical study, researchers sought to determine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback